NRX Pharmaceuticals Seeks New CEO for Drug Launches
Earnings Call: NRx Pharmaceuticals Outlines Key Business Advancements
NRx Pharmaceuticals, Inc. (NRXP) Q2 2024 Earnings Call Transcript Summary
NRx Pharmaceuticals, Inc. (NRXP) Q2 2024 Earnings Call Transcript
Express News | NRX Pharmaceuticals Q2 2024 GAAP EPS $(0.75) Misses $(0.58) Estimate
10-Q: Q2 2024 Earnings Report
NRx Pharmaceuticals (NASDAQ:NRXP) Reports Second Quarter and Year to Date 2024 Financial Results and Provides Business Update
Express News | NRX Pharmaceuticals (Nasdaq:Nrxp) Reports Second Quarter and Year to Date 2024 Financial Results and Provides Business Update
NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Report Second Quarter and Year to Date 2024 Financial Results on August 14, 2024
Express News | NRx Pharmaceuticals Has Obtained Up To Approximately $16M In Convertible Debt Financing From An Institutional Investor To Support The 2024 New Drug Application Filing Its Two Lead Products, NRX-100 And NRX-101 And To Retire Existing Debt From...
Express News | NRX Pharmaceuticals - Intends to Use Net Proceeds From Financing to Support Nda Filing of NRX-100 and NRX-101
Express News | NRX Pharmaceuticals, Inc. (Nasdaq:Nrxp) Announces up to $16 Million Senior Secured Debt Financing From Anson Funds
HC Wainwright & Co. Maintains Buy on NRX Pharmaceuticals, Adjusts Price Target To $19 (1-10 Reverse Stock Split)
NRX Pharmaceuticals Analyst Ratings
Express News | NRX Pharmaceuticals Inc: Remains on Track to File Nda for NRX-100 in Q4 2024 With Anticipated Pdufa Date in Q2 2025
Express News | Hope Therapeutics, Inc. and NRX Pharmaceuticals, Inc. (Nasdaq:Nrxp) Announce Alignment With FDA on Pediatric Study Plan for NRX-100 (Ketamine)
Express News | NRX Pharmaceuticals Inc - Petition to Prevent NRX Share Sales Denied by Utah Arbitrator
Express News | NRX Pharmaceuticals Inc - to Proceed With Spinoff of Hope Therapeutics
Express News | Hope Therapeutics, Inc. and NRX Pharmaceuticals (Nasdaq:Nrxp) Announce Arbitration Order Enabling Hope Therapeutics Spinoff
Express News | NRx Pharmaceuticals Outlines Potential Paths To Revenue And Profitability In 2025; New Shareholder Update Highlights Potential 2024 Revenue From HOPE Therapeutics-Branded Clinics, 2025 Revenue From Sales Of NRX-100 (IV Ketamine) Pending FDA Approval,...